druginteraction

Drug interaction refers to the influence that one medicinal substance exerts on the effect, efficacy, pharmacokinetics, or adverse effect profile of another drug when coadministered. These changes arise from pharmacodynamic or pharmacokinetic mechanisms. Pharmacodynamic interactions involve additive, synergistic, or antagonistic effects on the same or complementary physiological pathways, while pharmacokinetic interactions alter absorption, distribution, metabolism, or excretion, thereby changing a drug’s plasma concentration.

Common pharmacokinetic mechanisms include inhibition or induction of cytochrome P450 enzymes, modulation of drug transporters such as P‑glycoprotein, and competition for plasma protein binding. For example, omeprazole inhibits CYP2C19, increasing the levels of clopidogrel’s active metabolite, whereas rifampicin induces CYP3A4 and reduces antiretroviral concentrations. Pharmacodynamic examples encompass the additive sedative effect of benzodiazepines and opioids, or the QT‑interval prolongation when multiple QT‑prolonging agents are combined.

Clinical consequences of drug interactions range from therapeutic failure to severe toxicity. Adverse outcomes may include hemolysis from dapsone and sulfa drugs, serotonin syndrome from serotonergic agents combined with MAO inhibitors, or increased bleeding risk when anticoagulants are paired with nonsteroidal anti‑inflammatory drugs. Consequently, health professionals routinely assess medication history, review drug interaction databases, and monitor for signs of altered drug activity.

Preventive strategies involve medication reconciliation, careful selection of non‑interacting alternatives, dose adjustments, or staggered dosing schedules. Technological tools such as electronic health record alerts enhance early detection. In summary, drug interaction awareness is essential to safeguard therapeutic efficacy and patient safety.